Artificial Intelligence Ai Regulatory Affairs Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

AI in regulatory affairs refers to software and services that automate document drafting, submission assembly, compliance monitoring, and post-market surveillance for regulators and regulated companies. The market is sized at approximately USD 1.71 billion in 2025 and is on track to reach about USD 4.78 billion by 2030, implying a compound annual growth rate near 22.83%. Adoption is concentrated in life sciences but is broadening into financial services, energy, and telecommunications as compliance data volumes rise.

• •Estimated 2025 market value: USD 1.71 billion; projected 2030 value: USD 4.78 billion
• •Forecast CAGR of approximately 22.83% between 2025 and 2030
• •Core use cases include regulatory authoring, submission management, and compliance monitoring

The principal growth drivers are the rising volume and complexity of regulatory submissions, the shortage of regulatory affairs professionals, and the need to reduce human error in compliance documentation. New AI-specific rules such as the EU AI Act and the FDA's evolving guidance on AI/ML-enabled medical devices are simultaneously creating obligations and providing a clear use case for AI-assisted compliance tools.

• •Increasing global submission volumes to FDA, EMA, and other agencies strain manual workflows
• •Talent shortages in regulatory affairs push organizations toward automation
• •Emerging AI regulations themselves create new compliance requirements that AI tools help address

The market is commonly segmented by deployment mode (cloud and on-premises), component (software and services), application (regulatory intelligence, submission management, compliance tracking), and end-use industry, with pharmaceuticals and medical devices representing the largest verticals. North America, led by the United States, accounts for the largest share today, while Europe is the fastest-growing region as firms respond to the EU AI Act, MDR, and IVDR. The Asia-Pacific region is also expanding rapidly as China, Japan, and India modernize their regulatory frameworks.

• •Pharmaceutical and medical device companies are the dominant end users
• •Cloud-based deployment is gaining share over on-premises installations
• •North America leads in revenue; Europe and Asia-Pacific are the fastest-growing regions

What are the recent trends and outlook?

Through 2030, expect deeper use of generative AI for drafting clinical and regulatory documents, more automated regulatory intelligence, and stronger MLOps and model governance features designed to satisfy AI regulators. Acquisitions of niche AI-regulatory startups by larger life-sciences technology and CRO players are likely to accelerate as the category matures. Overall, the market is positioned to remain one of the faster-growing compliance software segments, although adoption will depend on validated accuracy, data security, and clear regulatory acceptance of AI-assisted submissions.

• •Generative AI for document drafting and regulatory intelligence is the dominant near-term trend
• •Consolidation is expected as large vendors acquire specialized AI-regulatory startups
• •Adoption will hinge on validated accuracy, data privacy, and regulator acceptance of AI-assisted submissions